Volume 152, Issue 3, Pages (February 2017)

Slides:



Advertisements
Similar presentations
Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial Cells  Kai Fang, Aristea.
Advertisements

Volume 133, Issue 1, Pages (July 2007)
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
Volume 145, Issue 4, Pages e2 (October 2013)
Volume 131, Issue 4, Pages (October 2006)
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Volume 144, Issue 3, Pages e4 (March 2013)
Volume 145, Issue 2, Pages (August 2013)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 132, Issue 5, Pages (May 2007)
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer  Yi-Chieh Yang, MS, Yen-An Tang,
Volume 140, Issue 2, Pages e2 (February 2011)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
Volume 138, Issue 1, Pages e3 (January 2010)
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Volume 135, Issue 5, Pages e24 (November 2008)
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 133, Issue 1, Pages (July 2007)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 137, Issue 4, Pages e3 (October 2009)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 136, Issue 5, Pages (May 2009)
Volume 138, Issue 3, Pages e4 (March 2010)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity  Jing Xue, Xuebing Li, Shi Jiao,
Volume 141, Issue 6, Pages (December 2011)
Volume 145, Issue 4, Pages e2 (October 2013)
Volume 25, Issue 4, Pages (April 2014)
Volume 138, Issue 2, Pages (February 2010)
Volume 146, Issue 2, Pages (February 2014)
Volume 131, Issue 4, Pages (October 2006)
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 136, Issue 2, Pages (February 2009)
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Volume 137, Issue 4, Pages (October 2009)
Volume 138, Issue 5, Pages e2 (May 2010)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 130, Issue 2, Pages (February 2006)
Volume 22, Issue 10, Pages (October 2014)
Volume 127, Issue 1, Pages (July 2004)
Molecular Therapy - Nucleic Acids
Volume 145, Issue 2, Pages (August 2013)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 140, Issue 3, Pages (March 2011)
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Volume 130, Issue 4, Pages (August 2007)
Volume 25, Issue 9, Pages (September 2017)
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 129, Issue 5, Pages (November 2005)
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
Volume 135, Issue 2, Pages e2 (August 2008)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 137, Issue 4, Pages (October 2009)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 19, Issue 8, Pages (August 2011)
Volume 132, Issue 2, Pages (February 2007)
Volume 127, Issue 4, Pages (October 2004)
Volume 16, Issue 9, Pages (August 2016)
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 136, Issue 7, Pages (June 2009)
Volume 25, Issue 11, Pages e6 (December 2018)
Volume 22, Issue 9, Pages (September 2014)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Volume 23, Issue 4, Pages (April 2015)
Presentation transcript:

Volume 152, Issue 3, Pages 631-643 (February 2017) Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis  Takeshi Yoshikawa, Jianfeng Wu, Motoyuki Otsuka, Takahiro Kishikawa, Nobumi Suzuki, Akemi Takata, Motoko Ohno, Rei Ishibashi, Mari Yamagami, Ryo Nakagawa, Naoya Kato, Masaaki Miyazawa, Jiahuai Han, Kazuhiko Koike  Gastroenterology  Volume 152, Issue 3, Pages 631-643 (February 2017) DOI: 10.1053/j.gastro.2016.10.043 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 Inflammatory stimuli reduce miRNA function. (A) miRNA function was restored by various inflammatory cytokines. Luciferase reporter constructs carrying corresponding miRNA binding sites in their 3′-UTRs were used to examine miRNA function. The suppressive effects of miRNA precursor expression (LET7B, left panel; MIR185, right panel) on luciferase activity were reversed by inflammatory cytokines in Caco-2 cells. Data represent the mean ± SD of 3 experiments. ∗P < .05. (B) Restoration of miRNA function by inflammatory stimuli was miRNA-dependent. Reporter activity suppression by the LET7B precursor was reversed by inflammatory stimuli in wild-type cells but not in Dicer-knockout cells. Data represent the mean ± SD of 3 experiments. ∗P < .05. (C) A luciferase reporter carrying a region of the LIN28B 3′-UTR (nucleotides 3351−3650) containing 2 putative LET7B target sites was used to assess the effect of LET7B on endogenous gene sequences. Putative binding sequences are indicated in red. (D) The effect of miRNA on a reporter carrying wild-type LIN28B sequences in Caco-2 cells was reversed by various inflammatory cytokines. Data represent the means ± SD of 3 experiments. ∗P < .05. (E) LIN28B and c-myc expression, both with 3′-UTRs that are LET7 targets, were up-regulated in Caco-2 cells by TNF. (F) Left panels: LIN28B mRNA was relocated from P-bodies to the cytosol after stimulation of Caco-2 cells with TNF. P-bodies were visualized by measuring GFP-Dcp1a (green), and LIN28B was visualized with in situ hybridization (red). 4′,6-Diamidino-2-phenylindole (blue) was used to stain nuclei. Bar = 25 μm. Right panels: The percentages of LIN28B dots co-localized with P-bodies are shown based on 60 cells from 3 independent experiments. Data represent the means ± SD. ∗P < .05. Gastroenterology 2017 152, 631-643DOI: (10.1053/j.gastro.2016.10.043) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 miRNA function is impaired during inflammation-associated colon tumorigenesis in vivo. (A) The construct for GFP-based reporter transgenic mice containing cytomegalovirus promoter-driven GFP complementary DNA with MIR29B, LET7B, and MIR122 target sequences in its 3′-UTR. (B) Representative images from 3 independent Western blot experiments for GFP expression in the liver 24 hours after injection of liposome-conjugated in vivo−ready anti-MIR122, anti- LET7B, or negative control oligonucleotides into the tail vein of reporter mice. GFP expression increased after administration of anti-MIR122 and anti-LET7B but not the negative control oligonucleotides. (C) Protocol for experimental inflammation-associated colon tumorigenesis used in this study. Colon tumors were induced by treatment with AOM plus DSS. (D) Immunohistochemical analyses of GFP expression in the colon before and after inducing inflammation. The sections shown are 30 mm proximal to the anal canal. Bars = 200 μm. Lower panels show magnified images of the glands in the upper panels. Similar results were obtained from 3 independent sets of mice. The bottom panels show anti-GFP stained images colon tissue of wild-type mice (non-reporter) as negative controls. (E) Representative Western blot images for GFP expression in isolated colonic epithelial cells before and after induction of inflammation. GFP expression increased after inducing inflammation. Gastroenterology 2017 152, 631-643DOI: (10.1053/j.gastro.2016.10.043) Copyright © 2017 AGA Institute Terms and Conditions

Figure 3 A3G protein levels decrease under cytokine stimulation. (A) HCT116 cells were treated with the indicated cytokines for 24 hours. Representative Western blot results are shown for 2 independent experiments. A3G protein levels decreased by TNF, IL1A, and IL1B treatment. Similar results were obtained using HT29 cells. (B) A3G promoter activities were not affected by TNF or IL8 treatment. The luciferase construct driven by the A3G promoter (upper) was transiently transfected into HCT116 cells, which were stimulated with cytokines for 24 hours before the assay. Relative luciferase levels were determined after the control sample levels were set to 1. Data represent the means ± SD of 3 independent experiments. (C) A3G mRNA decay was not enhanced by TNF. A3G mRNA levels in HCT116 after exposure to TNF for 24 hours were determined by quantitative reverse transcription polymerase chain reaction. To exclude the effects of newly transcribed mRNAs, actinomycin D (ActD) was added for 24 hours. Data represent the means ± SD of 3 independent experiments. (D) A3G protein degradation was enhanced by TNF. Representative images are shown for 2 independent experiments. M, marker. (E) Ubiquitination of A3G protein was enhanced by TNF. HCT116 cells were transiently transfected with HA-tagged ubiquitin-expressing plasmids. A3G proteins were precipitated with anti-A3G antibodies 3 hours after adding TNF. Ubiquitination was analyzed by Western blotting using anti-HA antibodies. The results shown are representative of 3 independent experiments, and 5% of the total cell lysate was used as an internal control (“input”). Gastroenterology 2017 152, 631-643DOI: (10.1053/j.gastro.2016.10.043) Copyright © 2017 AGA Institute Terms and Conditions

Figure 4 miRNA levels recruited into RISCs decrease under inflammatory cytokines. (A) A3G binds with Ago2. HCT116 cells were treated or untreated with TNF for 24 hours, followed by immunoprecipitation using mouse anti-Ago2 antibody. Mouse IgG was used as a negative control. Precipitated lysates were used for Western blots with antibodies against the indicated proteins, and 5% of the total cell lysate was used as an internal control (“input”). The results are representative of 4 independent experiments. (B) HCT116 cells transiently transfected with halo-tagged A3G-expressing plasmids were treated or untreated with TNF for 24 hours. Cells were immunostained using antibodies against Ago2 (green) and halo (red). Nuclei were stained with 4′,6-diamidino-2-phenylindole. Representative images are shown for 3 independent experiments. Bar = 25 μm. (C, D) TNF decreased miRNA loading into RISCs. RISCs in HCT116 cells were precipitated. LET7B levels in the complexes were determined with quantitative reverse transcription polymerase chain reaction. Left: A3G knockdown (shA3G) decreased the loading levels. Right: A3G overexpression reversed the decreased loading of LET7B induced by TNF. IL8 was used as a negative control. LET7B levels in RISCs from the control samples were set to 1. Data represent the means ± SD of 3 experiments. The lower panels show A3G and Ago2 protein levels in the total cell lysate determined with Western blots. ∗P < .05. (E) Confirmation of APOBEC3 protein in wild-type (+/+) and Apobec3-deleted (−/−) MEFs by Western blotting. Representative images of 2 experiments are shown. (F) Reporter activity suppressed by LET7B was de-repressed in Apobec3-deleted MEFs. Similar effects were observed irrespective of LET7B precursor overexpression. Data represent the means ± SD of 3 experiments. White bars: wild-type (+/+) MEFs; black bars: Apobec3-deleted (−/−) MEFs. ∗P < .05. Gastroenterology 2017 152, 631-643DOI: (10.1053/j.gastro.2016.10.043) Copyright © 2017 AGA Institute Terms and Conditions

Figure 5 A3G protein levels in colon epithelia decrease by chronic inflammation. (A) Ago2 and APOBEC3 protein levels in mouse colon epithelial cells before and after 3 cycles of DSS treatment, determined with Western blots. Representative images of 2 independent experiments using 3 mice in each group are shown. (B) APOBEC3 protein expression levels in mouse colon epithelia decreased after one cycle of DSS treatment, determined by immunohistochemistry. Ago2 protein was stained for comparison. Similar results were obtained from 3 independent sets of mice. Bars = 200 μm. (C) Mature miRNA expression levels in mouse colon epithelial cells were similar before and after 1 cycle of DSS treatment, determined using quantitative reverse transcription polymerase chain reaction (qRT-PCR). Relative expression levels are shown as the means ± SD of 2 independent experiments using 3 mice in each group, after adjusting the values from the cells before DSS treatment to 1. ∗P < .05. (D) The levels of Ago2 protein immunoprecipitated from isolated mouse colon epithelial cells before and after 1 cycle of DSS treatment were comparable, determined with Western blots. The results of 2 mice in each group are shown. Immunoprecipitation using control IgG was used as a negative control, and 10% of the samples before immunoprecipitation are shown as an internal control (“input”). (E) miRNA levels loaded into RISCs in mouse colon epithelial cells decreased after 1 cycle of DSS treatment. RISCs in the isolated mouse colon epithelial cells were immunoprecipitated. miRNA levels in the complexes were determined by qRT-PCR. Data represent the means ± SD of 2 independent experiments using 2 mice in each group. Only minimal miRNAs were detected in the precipitants precipitated with control normal IgG. ∗P < .05. (F) The protein expression status in human tissues from control and ulcerative colitis patients was determined using immunohistochemistry. Consecutive sections from each patient were stained (in brown) with antibodies against the indicated proteins. Representative results from 3 cases in each group are shown. Bars = 500 μm. Gastroenterology 2017 152, 631-643DOI: (10.1053/j.gastro.2016.10.043) Copyright © 2017 AGA Institute Terms and Conditions

Figure 6 Enhancing miRNA function suppresses inflammation-associated colon tumorigenesis. (A) Fasudil, a ROCK inhibitor, enhanced miRNA function in mice after induction of colon inflammation, as determined by immunohistochemical analysis of GFP expression in reporter transgenic mice at day 62. The sections shown are 30 mm proximal to the anal canal. Bars = 200 μm. The lower panels show magnified images of the glands in the upper panels. Similar results were obtained from 3 independent sets of mice. (B) Body weight changes in mice treated with fasudil (n = 12) and in nontreated controls (n = 12) during DSS-induced colon inflammation. Body weight loss was similar in the control and fasudil groups. (C) Colon length was measured on day 62 in control and fasudil-treated mice. Data represent the means ± SD (n = 12 per group). The final colon length was similar in the control and fasudil groups. (D) Inflammatory scores of mice from each group (n = 12 per group). The inflammatory scores in the histologic analysis were similar in the control and fasudil groups. (E, F) Fewer tumors were detected in fasudil-treated mice. Representative colon images are shown in (E). Bars = 5 mm. Mean numbers of tumors per mouse ± SD (n = 12 per group) are shown in (F). ∗P < .05. Gastroenterology 2017 152, 631-643DOI: (10.1053/j.gastro.2016.10.043) Copyright © 2017 AGA Institute Terms and Conditions